Skip to content

Clinical trials

Heart Failure, Systolic trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure, Systolic Country / region: China Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20141
20211
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting2
Active, not recruiting1
Completed1
Enrolling by invitation1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation1
Ruijin Hospital Luwan Branch1
Salubris Biotherapeutics Inc1
Shanghai East Hospital1
Shanghai Zhongshan Hospital1
Sunnybrook Health Sciences Centre1
The University of Hong Kong-Shenzhen Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure, Systolic7
Heart Failure5
Atrial Fibrillation1
Atrial Flutter1
Bundle-Branch Block1
Coronary Artery Disease1
Death, Sudden, Cardiac1
Heart Failure, Diastolic1
Ventricular Dysfunction, Left1

Trials

Showing 26 to 7 of 7. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.